IN just its fourth year on the Chinese mainland, Medimaging Integrated Solution Inc. (MiiS), a Taiwan-based enterprise specializing in digital and portable diagnostic solutions, is already on the cusp of becoming an A-share listed company.

The company was set up in the Dongguan Songshan Lake Hi-Tech Industrial Development Zone in Guangdong Province, where a series of preferential policies concerning technological innovation, financial support and human resources were carried out to encourage investment.

Thanks to a plan unveiled in 2014 by the Dongguan government to attract Taiwan biotechnology companies, MiiS enjoyed a yearly subsidy of 5 million yuan (US$726,500) for reaching its goals three years in a row, while taking its sales to 30 million yuan in 2018, up nearly 40 percent year on year.

Courtesy of the favorable policies and the investment-friendly business environment, a total of 20 Taiwan-based biotechnology enterprises have now settled in the development zone to grasp opportunities in the upgrading market.

Carol, the largest microphone manufacturer in Asia, which was founded in Taichung over 40 years ago, is another Taiwan enterprise taking advantage of the mainland’s policies and has handled the wave of renewal well with its advanced technologies and crafted products.

Having set up its branch in Shenzhen in 1993, it now boasts 127 patents and produces 300,000 microphones per month with over US$30 million in annual sales.

As of July 2018, a total of 6,138 Taiwan-based companies had set foot in Shenzhen, accounting for around US$9.98 billion of investment from Taiwan. (Xinhua)